If you are looking for a deeply undervalued AI stock that is more promising than AZN but that trades at less than 5 times its ...
Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a £110 ($143.19) price objective on shares of ...
This compares with $11.49 billion for the same period the year before. As of Friday's close, AstraZeneca's stock was down 6.6% since the start of 2024 and about 1.85% over the last 12 months. WHAT TO ...
Check the time stamp on this data. Updated AI-Generated Signals for Astrazeneca Plc (AZN) available here: AZN.
Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...
AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...
Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...
AstraZeneca (AZN) shares tumble amid intensifying concerns about a Chinese probe into the drugmaker. Josh Lipton and Julie ...
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.